Staidson (Beijing) BioPharmaceuticals Co., Ltd. - Current Ratio

The Current Ratio as of August 2026 (TTM) for Staidson (Beijing) BioPharmaceuticals Co., Ltd. (300204.SZ) is 2.00

According to Staidson (Beijing) BioPharmaceuticals Co., Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 2.00. This represents a change of -5.65% compared to the average of 2.12 of the last 4 quarters.

Staidson (Beijing) BioPharmaceuticals Co., Ltd. (300204.SZ) Historical Current Ratio (quarterly & annually)

How has 300204.SZ Current Ratio performed in the past?

The mean historical Current Ratio of Staidson (Beijing) BioPharmaceuticals Co., Ltd. over the last ten years is 3.61. The current 2.00 Current Ratio has changed 5.45% with respect to the historical average. Over the past ten years (40 quarters), 300204.SZ's Current Ratio was at its highest in in the March 2020 quarter at 6.76. The Current Ratio was at its lowest in in the September 2024 quarter at 1.10.

Staidson (Beijing) BioPharmaceuticals Co., Ltd. (300204.SZ) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Staidson (Beijing) BioPharmaceuticals Co., Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Staidson (Beijing) BioPharmaceuticals Co., Ltd. (300204.SZ) Average Current Ratio

How has 300204.SZ Current Ratio performed in the past?

The current Current Ratio of Staidson (Beijing) BioPharmaceuticals Co., Ltd. (300204.SZ) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Staidson (Beijing) BioPharmaceuticals Co., Ltd. (300204.SZ) Current Ratio vs. Peers

How is 300204.SZ’s Current Ratio compared to its peers?

Staidson (Beijing) BioPharmaceuticals Co., Ltd.’s Current Ratio is greater than Mabwell (Shanghai) Bioscience Co., Ltd. (0.88), less than Yunnan Botanee Bio-Technology Group Co.LTD (3.63), less than Anhui Anke Biotechnology (Group) Co., Ltd. (4.30), less than Inner Mongolia Furui Medical Science Co., Ltd. (3.44), greater than DaShenLin Pharmaceutical Group Co., Ltd. (0.93), greater than Fujian Cosunter Pharmaceutical Co., Ltd. (1.02), less than Beijing Hotgen Biotech Co., Ltd. (6.74), greater than Porton Pharma Solutions Ltd. (1.85), less than Shenzhen Kangtai Biological Products Co., Ltd. (2.87), less than Winning Health Technology Group Co., Ltd. (3.13),

Build a custom stock screener for Staidson (Beijing) BioPharmaceuticals Co., Ltd. (300204.SZ) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Staidson (Beijing) BioPharmaceuticals Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Staidson (Beijing) BioPharmaceuticals Co., Ltd. (300204.SZ) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Staidson (Beijing) BioPharmaceuticals Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.